Showing results (271-280 of 439) with videos related to

Sort By:
Pageof 44
JACC. Advances|January 29, 2026
Empagliflozin in Heart Failure and Previous Coronary Revascularization: Insights From EMPEROR-PooledNitish K Dhingra, Javed Butler, Stefan D Anker, et al.
European Journal of Heart Failure|March 5, 2024
Carbohydrate antigen 125 concentrations across the ejection fraction spectrum in chronic heart failure: The EMPEROR programmeJoão Pedro Ferreira, Milton Packer, Naveed Sattar, et al.
Circulation|June 28, 2022
Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without DiabetesGerasimos Filippatos, Javed Butler, Dimitrios Farmakis, et al.
Journal of the American College of Cardiology|July 3, 2007
Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke DatabankG Michael Felker, Larry A Allen, Stuart J Pocock, et al.
JACC. Cardiovascular Interventions|November 21, 2015
Diagnostic and Prognostic Implications of Coronary Flow Capacity: A Comprehensive Cross-Modality Physiological Concept in Ischemic Heart DiseaseTim P van de Hoef, Mauro Echavarría-Pinto, Martijn A van Lavieren, et al.
European Heart Journal|October 26, 2012
Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studiesStuart J Pocock, Cono A Ariti, John J V McMurray, et al.
European Journal of Heart Failure|April 8, 2024
Insulin-like growth factor binding protein-7 concentrations in chronic heart failure: Results from the EMPEROR programmeJoão Pedro Ferreira, Milton Packer, Naveed Sattar, et al.
Diabetes Care|May 13, 2011
Incidence and prevalence of unrecognized myocardial infarction in people with diabetes: a substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD) studyMichael R MacDonald, Mark C Petrie, Philip D Home, et al.
JACC. Heart Failure|October 11, 2020
Estimating the Lifetime Benefits of Treatments for Heart FailureJoão Pedro Ferreira, Kieran F Docherty, Susan Stienen, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 4, 2021
Long-Term Antithrombotic Therapy and Clinical Outcomes in Patients with Acute Coronary Syndrome and Renal Impairment: Insights from EPICOR and EPICOR AsiaYong Huo, Frans Van de Werf, Yaling Han, et al.
Pageof 44